INDUSTRY OVERVIEW
The Plant Genomics is Growing at 17.90% and is expected to reach 11.2Billion by 2032. Below mentioned are some of the dynamics shaping the Plant Genomics.Plant Genomics Market Size in (USD Billion) CAGR Growth Rate 17.90%
| Study Period | 2020-2032 |
| Market Size (2024): | 3.6Billion |
| Market Size (2032): | 11.2Billion |
| CAGR (2024 - 2032): | 17.90% |
| Fastest Growing Region | Asia-Pacific |
| Dominating Region | North America |
www.www.htfmarketinsights.com
Plant genomics involves sequencing and editing plant DNA to enhance traits like drought resistance, yield, and nutritional content. CRISPR-Cas9, TALENs, and RNAi technologies enable precise modifications, while AI accelerates gene discovery. Applications include biofortified crops (Golden Rice), disease-resistant varieties (TR4-proof bananas), and climate-adaptive strains (flood-tolerant rice). The market also supports vertical farming (optimized indoor crops) and synthetic biology (plant-based drug production). Regulatory hurdles and GMO skepticism remain challenges, but gene-edited non-GMO crops are gaining acceptance.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
- Climate-resilient Crop Needs
- CRISPR Adoption Acceleration
- Seed Patent Landscapes
- Vertical Farming Optimization
- Phytopharmaceutical Demand
Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
- GMO Regulatory Hurdles
- Gene Drive Ecological Concerns
- Data Interoperability Issues
- Intellectual Property Disputes
- Phenotyping Automation Gaps
Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
- Multi-omics data integration
- AI-driven trait prediction
- open-source genome databases
- drought-tolerance gene editing
- rapid generation advancement
Market Opportunities:
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
- Expansion In African Staple Crop Projects
- Adoption In Cannabis Breeding
- R&D In Perennial Wheat
- Customization For Arid Region Agriculture
- Partnerships With Seed Banks
Check Out Prices
Get Price
Regulation Shaping the Healthcare Industry
The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.Major Regulatory Bodies Worldwide
1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization
SWOT Analysis in the Healthcare Industry
SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.• Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
• Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
• Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
• Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.
Market Segmentation
Segmentation by Type
- CRISPR crops
- drought-resistant seeds
- high-yield varieties
- disease-resistant plants
Plant Genomics Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
- Agriculture
- biotech research
- food security
- climate adaptation
- seed production
Plant Genomics Market Segmentation by Application
www.htfmarketinsights.com
Regional Outlook
The North America currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, Asia-Pacific is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, includingRegions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
Asia-Pacific
Dominating Region
North America
The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
- Bayer (Climate LLC)
- Corteva Agriscience
- Syngenta
- BASF
- KeyGene
- Benson Hill
- Pairwise
- NRGene
- Evogene
- Novozymes
- Eurofins Genomics
- Illumina
- Pacific Biosciences
- Oxford Nanopore
- Editas Medicine
- Caribou Biosciences
- CRISPR Therapeutics
- Arcadia Biosciences
- Hudson River Biotechnology
Plant Genomics Market Segmentation by Players
www.htfmarketinsights.com
Primary and Secondary Research
Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.
Report Infographics
|
Report Features |
Details |
|
Base Year |
2024 |
|
Based Year Market Size (2023) |
3.6Billion |
|
Historical Period |
2020 to 2024 |
|
CAGR (2024 to 2032) |
17.90% |
|
Forecast Period |
2024 to 2032 |
|
Forecasted Period Market Size (2032) |
11.2Billion |
|
Scope of the Report |
Segmentation by Type CRISPR crops, drought-resistant seeds, high-yield varieties, disease-resistant plants, Segmentation by Application Agriculture, biotech research, food security, climate adaptation, seed production, Sales Channel |
|
Regions Covered |
North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
|
Companies Covered |
Bayer (Climate LLC), Corteva Agriscience, Syngenta, BASF, KeyGene, Benson Hill, Pairwise, NRGene, Evogene, Novozymes, Eurofins Genomics, Illumina, Pacific Biosciences, Oxford Nanopore, Editas Medicine, Caribou Biosciences, CRISPR Therapeutics, Arcadia Biosciences, Hudson River Biotechnology |
|
Customization Scope |
15% Free Customization (For EG) |
|
Delivery Format |
PDF and Excel through Email |
Plant Genomics - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Plant Genomics Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Plant Genomics Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Plant Genomics Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Climate-resilient crop needs
- 3.1.2 CRISPR adoption acceleration
- 3.1.3 seed patent landscapes
- 3.1.4 vertical farming optimization
- 3.1.5 phytopharmaceutical demand
-
3.2 Available Opportunities
- 3.2.1 Expansion in African staple crop projects
- 3.2.2 adoption in cannabis breeding
- 3.2.3 R&D in perennial wheat
- 3.2.4 customization f
-
3.3 Influencing Trends
- 3.3.1 Multi-omics data integration
- 3.3.2 AI-driven trait prediction
- 3.3.3 open-source genome databases
- 3.3.4 drought-tolerance gene ed
-
3.4 Challenges
- 3.4.1 GMO regulatory hurdles
- 3.4.2 gene drive ecological concerns
- 3.4.3 data interoperability issues
- 3.4.4 intellectual property dispu
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Plant Genomics Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Plant Genomics Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: Plant Genomics : Competition Benchmarking & Performance Evaluation
- 5.1 Global Plant Genomics Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Plant Genomics Revenue 2024
- 5.3 Global Plant Genomics Sales Volume by Manufacturers (2024)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 FPNV Positioning Matrix
- 5.6 Heat Map Analysis
Chapter 6: Global Plant Genomics Market: Company Profiles
- 6.1 Bayer (Climate LLC)
- 6.1.1 Bayer (Climate LLC) Company Overview
- 6.1.2 Bayer (Climate LLC) Product/Service Portfolio & Specifications
- 6.1.3 Bayer (Climate LLC) Key Financial Metrics
- 6.1.4 Bayer (Climate LLC) SWOT Analysis
- 6.1.5 Bayer (Climate LLC) Development Activities
- 6.2 Corteva Agriscience
- 6.3 Syngenta
- 6.4 BASF
- 6.5 KeyGene
- 6.6 Benson Hill
- 6.7 Pairwise
- 6.8 NRGene
- 6.9 Evogene
- 6.10 Novozymes
- 6.11 Eurofins Genomics
- 6.12 Illumina
- 6.13 Pacific Biosciences
- 6.14 Oxford Nanopore
- 6.15 Editas Medicine
- 6.16 Caribou Biosciences
- 6.17 CRISPR Therapeutics
- 6.18 Arcadia Biosciences
- 6.19 Hudson River Biotechnology
- 6.20 Tropic Biosciences
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Plant Genomics by Type & Application (2020-2032)
-
7.1 Global Plant Genomics Market Revenue Analysis (USD Million) by Type (2020-2024)
- 7.1.1 CRISPR Crops
- 7.1.2 Drought-resistant Seeds
- 7.1.3 High-yield Varieties
- 7.1.4 Disease-resistant Plants
- 7.1.5 Biofortified Crops
-
7.2 Global Plant Genomics Market Revenue Analysis (USD Million) by Application (2020-2024)
- 7.2.1 Agriculture
- 7.2.2 Biotech Research
- 7.2.3 Food Security
- 7.2.4 Climate Adaptation
- 7.2.5 Seed Production
- 7.3 Global Plant Genomics Market Revenue Analysis (USD Million) by Type (2024-2032)
- 7.4 Global Plant Genomics Market Revenue Analysis (USD Million) by Application (2024-2032)
Chapter 8 : North America Plant Genomics Market Breakdown by Country, Type & Application
- 8.1 North America Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 8.2.1 CRISPR Crops
- 8.2.2 Drought-resistant Seeds
- 8.2.3 High-yield Varieties
- 8.2.4 Disease-resistant Plants
- 8.2.5 Biofortified Crops
-
8.3 North America Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 8.3.1 Agriculture
- 8.3.2 Biotech Research
- 8.3.3 Food Security
- 8.3.4 Climate Adaptation
- 8.3.5 Seed Production
- 8.4 North America Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 8.5 North America Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 8.6 North America Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Plant Genomics Market Breakdown by Country, Type & Application
- 9.1 LATAM Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 9.2.1 CRISPR Crops
- 9.2.2 Drought-resistant Seeds
- 9.2.3 High-yield Varieties
- 9.2.4 Disease-resistant Plants
- 9.2.5 Biofortified Crops
-
9.3 LATAM Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 9.3.1 Agriculture
- 9.3.2 Biotech Research
- 9.3.3 Food Security
- 9.3.4 Climate Adaptation
- 9.3.5 Seed Production
- 9.4 LATAM Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 9.5 LATAM Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 9.6 LATAM Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 10 : West Europe Plant Genomics Market Breakdown by Country, Type & Application
- 10.1 West Europe Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 10.2.1 CRISPR Crops
- 10.2.2 Drought-resistant Seeds
- 10.2.3 High-yield Varieties
- 10.2.4 Disease-resistant Plants
- 10.2.5 Biofortified Crops
-
10.3 West Europe Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 10.3.1 Agriculture
- 10.3.2 Biotech Research
- 10.3.3 Food Security
- 10.3.4 Climate Adaptation
- 10.3.5 Seed Production
- 10.4 West Europe Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 10.5 West Europe Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 10.6 West Europe Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 11 : Central & Eastern Europe Plant Genomics Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 11.2.1 CRISPR Crops
- 11.2.2 Drought-resistant Seeds
- 11.2.3 High-yield Varieties
- 11.2.4 Disease-resistant Plants
- 11.2.5 Biofortified Crops
-
11.3 Central & Eastern Europe Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 11.3.1 Agriculture
- 11.3.2 Biotech Research
- 11.3.3 Food Security
- 11.3.4 Climate Adaptation
- 11.3.5 Seed Production
- 11.4 Central & Eastern Europe Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 11.5 Central & Eastern Europe Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 11.6 Central & Eastern Europe Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 12 : Northern Europe Plant Genomics Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 12.2.1 CRISPR Crops
- 12.2.2 Drought-resistant Seeds
- 12.2.3 High-yield Varieties
- 12.2.4 Disease-resistant Plants
- 12.2.5 Biofortified Crops
-
12.3 Northern Europe Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 12.3.1 Agriculture
- 12.3.2 Biotech Research
- 12.3.3 Food Security
- 12.3.4 Climate Adaptation
- 12.3.5 Seed Production
- 12.4 Northern Europe Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 12.5 Northern Europe Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 12.6 Northern Europe Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 13 : Southern Europe Plant Genomics Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 13.2.1 CRISPR Crops
- 13.2.2 Drought-resistant Seeds
- 13.2.3 High-yield Varieties
- 13.2.4 Disease-resistant Plants
- 13.2.5 Biofortified Crops
-
13.3 Southern Europe Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 13.3.1 Agriculture
- 13.3.2 Biotech Research
- 13.3.3 Food Security
- 13.3.4 Climate Adaptation
- 13.3.5 Seed Production
- 13.4 Southern Europe Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 13.5 Southern Europe Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 13.6 Southern Europe Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 14 : East Asia Plant Genomics Market Breakdown by Country, Type & Application
- 14.1 East Asia Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 14.2.1 CRISPR Crops
- 14.2.2 Drought-resistant Seeds
- 14.2.3 High-yield Varieties
- 14.2.4 Disease-resistant Plants
- 14.2.5 Biofortified Crops
-
14.3 East Asia Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 14.3.1 Agriculture
- 14.3.2 Biotech Research
- 14.3.3 Food Security
- 14.3.4 Climate Adaptation
- 14.3.5 Seed Production
- 14.4 East Asia Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 14.5 East Asia Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 14.6 East Asia Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 15 : Southeast Asia Plant Genomics Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 15.2.1 CRISPR Crops
- 15.2.2 Drought-resistant Seeds
- 15.2.3 High-yield Varieties
- 15.2.4 Disease-resistant Plants
- 15.2.5 Biofortified Crops
-
15.3 Southeast Asia Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 15.3.1 Agriculture
- 15.3.2 Biotech Research
- 15.3.3 Food Security
- 15.3.4 Climate Adaptation
- 15.3.5 Seed Production
- 15.4 Southeast Asia Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 15.5 Southeast Asia Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 15.6 Southeast Asia Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 16 : South Asia Plant Genomics Market Breakdown by Country, Type & Application
- 16.1 South Asia Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 16.2.1 CRISPR Crops
- 16.2.2 Drought-resistant Seeds
- 16.2.3 High-yield Varieties
- 16.2.4 Disease-resistant Plants
- 16.2.5 Biofortified Crops
-
16.3 South Asia Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 16.3.1 Agriculture
- 16.3.2 Biotech Research
- 16.3.3 Food Security
- 16.3.4 Climate Adaptation
- 16.3.5 Seed Production
- 16.4 South Asia Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 16.5 South Asia Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 16.6 South Asia Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 17 : Central Asia Plant Genomics Market Breakdown by Country, Type & Application
- 17.1 Central Asia Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 17.2.1 CRISPR Crops
- 17.2.2 Drought-resistant Seeds
- 17.2.3 High-yield Varieties
- 17.2.4 Disease-resistant Plants
- 17.2.5 Biofortified Crops
-
17.3 Central Asia Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 17.3.1 Agriculture
- 17.3.2 Biotech Research
- 17.3.3 Food Security
- 17.3.4 Climate Adaptation
- 17.3.5 Seed Production
- 17.4 Central Asia Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 17.5 Central Asia Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 17.6 Central Asia Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 18 : Oceania Plant Genomics Market Breakdown by Country, Type & Application
- 18.1 Oceania Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 18.2.1 CRISPR Crops
- 18.2.2 Drought-resistant Seeds
- 18.2.3 High-yield Varieties
- 18.2.4 Disease-resistant Plants
- 18.2.5 Biofortified Crops
-
18.3 Oceania Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 18.3.1 Agriculture
- 18.3.2 Biotech Research
- 18.3.3 Food Security
- 18.3.4 Climate Adaptation
- 18.3.5 Seed Production
- 18.4 Oceania Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 18.5 Oceania Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 18.6 Oceania Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 19 : MEA Plant Genomics Market Breakdown by Country, Type & Application
- 19.1 MEA Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 19.2.1 CRISPR Crops
- 19.2.2 Drought-resistant Seeds
- 19.2.3 High-yield Varieties
- 19.2.4 Disease-resistant Plants
- 19.2.5 Biofortified Crops
-
19.3 MEA Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 19.3.1 Agriculture
- 19.3.2 Biotech Research
- 19.3.3 Food Security
- 19.3.4 Climate Adaptation
- 19.3.5 Seed Production
- 19.4 MEA Plant Genomics Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 19.5 MEA Plant Genomics Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 19.6 MEA Plant Genomics Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The Global Plant Genomics market is estimated to see a CAGR of 17.90% and may reach an estimated market size of 17.90% 11.2Billion by 2032.
The Plant Genomics Market is predicted to grow at a CAGR of 17.90%.
The changing dynamics and trends such as Multi-omics Data Integration, AI-driven Trait Prediction, Open-source Genome Databases, Drought-tolerance Gene Editing, Rapid Generation Advancement, Wild Crop Relative Sequencing are seen as major Game Changer in Global Plant Genomics Market.
- Climate-resilient Crop Needs
- CRISPR Adoption Acceleration
- Seed Patent Landscapes
- Vertical Farming Optimization
- Phytopharmaceutical Demand
- Biodiversity Loss Mitigation
Business transformation in Plant Genomics Market has taken hold due to the confluence of several important triggers, some of them are GMO Regulatory Hurdles, Gene Drive Ecological Concerns, Data Interoperability Issues, Intellectual Property Disputes, Phenotyping Automation Gaps, Public Sector Funding Limitations.
The market opportunity is clear from the flow of investment into Global Plant Genomics Market, some of them are Expansion In African Staple Crop Projects, Adoption In Cannabis Breeding, R&D In Perennial Wheat, Customization For Arid Region Agriculture, Partnerships With Seed Banks, Synthetic Biology Convergence.
Bayer (Climate LLC), Corteva Agriscience, Syngenta, BASF, KeyGene, Benson Hill, Pairwise, NRGene, Evogene, Novozymes, Eurofins Genomics, Illumina, Pacific Biosciences, Oxford Nanopore, Editas Medicine, Caribou Biosciences, CRISPR Therapeutics, Arcadia Biosciences, Hudson River Biotechnology, Tropic Biosciences etc are the main players listed in the Global Plant Genomics Market Study.
Research paper of Global Plant Genomics Market shows that companies are making better progress than their supply chain peers –including suppliers, majorly in end-use applications such as Agriculture, biotech research, food security, climate adaptation, seed production.
The Global Plant Genomics Market Study is segmented by CRISPR crops, drought-resistant seeds, high-yield varieties, disease-resistant plants, biofortified crops.
The Global Plant Genomics Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
The Plant Genomics Market is studied from 2020 - 2032.
Plant genomics involves sequencing and editing plant DNA to enhance traits like drought resistance, yield, and nutritional content. CRISPR-Cas9, TALENs, and RNAi technologies enable precise modifications, while AI accelerates gene discovery. Applications include biofortified crops (Golden Rice), disease-resistant varieties (TR4-proof bananas), and climate-adaptive strains (flood-tolerant rice). The market also supports vertical farming (optimized indoor crops) and synthetic biology (plant-based drug production). Regulatory hurdles and GMO skepticism remain challenges, but gene-edited non-GMO crops are gaining acceptance.
